← back to search

Min Xu

Zhejiang Chinese Medical University · CN
Area of research
Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Diabetes, Cardiovascular Risks, and Lipoproteins, Cardiovascular Health and Risk Factors, Liver Disease Diagnosis and Treatment, and Adipokines, Inflammation, and Metabolic Diseases.
h-index
16
citations
1,360
works
88
NIH funding
primary concept
Medicine
email

Recent publications

Formononetin-derived quantum dots suppress colon cancer growth by triggering mitochondrial apoptosis
Nanomedicine 2026cited by 1position: middledoi
Life’s Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China
Cardiovascular Diabetology 2025cited by 10position: middledoi
Heterogeneity of diabetes and disease progression with a tree-like representation: findings from the China Cardiometabolic Disease and Cancer Cohort (4C) study
Diabetologia 2025cited by 6position: middledoi
Association of circulating long-chain free fatty acids and incident diabetes risk among normoglycemic Chinese adults: a prospective nested case–control study
American Journal of Clinical Nutrition 2024cited by 10position: middledoi
Gallstones, cholecystectomy, and cancer risk: an observational and Mendelian randomization study
Frontiers of Medicine 2024cited by 8position: middledoi
An adversarial network used for drift correction in electronic nose
Sensors and Actuators A Physical 2024cited by 8position: middledoi
Interplay of Sphingolipid Metabolism in Predicting Prognosis of GBM Patients: Towards Precision Immunotherapy
Journal of Cancer 2023cited by 35position: lastdoi
Association of Spousal Diabetes Status and Ideal Cardiovascular Health Metrics With Risk of Incident Diabetes Among Chinese Adults
JAMA Network Open 2023cited by 4position: middledoi
Early adulthood weight change, midlife “Life’s essential 8” health status and risk of cardiometabolic diseases: a chinese nationwide cohort study
Nutrition & Metabolism 2023cited by 2position: middledoi
Amino acids, microbiota-related metabolites, and the risk of incident diabetes among normoglycemic Chinese adults: Findings from the 4C study
Cell Reports Medicine 2022cited by 61position: middledoi
Association of Serum Bile Acids Profile and Pathway Dysregulation With the Risk of Developing Diabetes Among Normoglycemic Chinese Adults: Findings From the 4C Study
Diabetes Care 2020cited by 87position: middledoi
Early Life Famine Exposure, Ideal Cardiovascular Health Metrics, and Risk of Incident Diabetes: Findings From the 4C Study
Diabetes Care 2020cited by 64position: middledoi
Individual and Combined Associations of Modifiable Lifestyle and Metabolic Health Status With New-Onset Diabetes and Major Cardiovascular Events: The China Cardiometabolic Disease and Cancer Cohort (4C) Study
Diabetes Care 2020cited by 63position: middledoi
Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A1c on Risk of Diabetes and Complications in Chinese Adults
Diabetes Care 2019cited by 179position: middledoi
High-Coverage Targeted Lipidomics Reveals Novel Serum Lipid Predictors and Lipid Pathway Dysregulation Antecedent to Type 2 Diabetes Onset in Normoglycemic Chinese Adults
Diabetes Care 2019cited by 147position: middledoi
Glycemic status and chronic kidney disease in <scp>C</scp>hinese adults: <scp>F</scp>indings from the <scp>REACTION</scp> study
Journal of Diabetes 2016cited by 13position: middledoi
Risk of renal cancer in liver transplant recipients: A systematic review and meta-analysis
International Journal of Surgery 2015cited by 9position: middledoi
Cohort profile: Risk evaluation of cancers in <scp>C</scp>hinese diabetic individuals: a longitudinal (<scp>REACTION</scp>) study (队列简介:中国糖尿病患者肿瘤发生风险的纵向研究(REACTION研究))
Journal of Diabetes 2013cited by 187position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shujing Zhou · Huazhong Agricultural University1 papers (2023–2023) · 1 papers (2019–2019)Huading Tai · Guiyang Medical University1 papers (2023–2023)Pen Chen · Nantong University1 papers (2015–2015)Qier Pan · Jiangsu University1 papers (2023–2023)Shuangyuan Wang · Ruijin Hospital1 papers (2019–2019) · 1 papers (2026–2026) · 1 papers (2026–2026) · 1 papers (2026–2026)Yufang Bi · Shanghai Jiao Tong University1 papers (2019–2019)Xu‐Feng Huang · University of Birmingham1 papers (2023–2023)Sin Man Lam · National University of Singapore1 papers (2019–2019)Jieli Lu · Shihezi University1 papers (2019–2019)Yi Zhang · Anhui Medical University1 papers (2015–2015)Jingzhe Wang · Ministry of Education of the People's Republic of China1 papers (2015–2015) · 1 papers (2023–2023)Qingming Jiang · Guangxi University1 papers (2024–2024)Lixin Shi · Guiyang Medical University1 papers (2019–2019)Hanjin Hou · Jiangsu University1 papers (2023–2023)Xulei Tang · Bond University1 papers (2019–2019)